Dimensional Fund Advisors
SBBP

Dimensional Fund Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

Dimensional Fund Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-576,979
Closed -$1.18M – 3601
2021
Q3 		$1.18M Buy
576,979
+23,438
+4% +$54.6K ﹤0.01% 3009
2021
Q2 		$1.64M Buy
553,541
+339,500
+159% +$896K ﹤0.01% 2923
2021
Q1 		$590K Buy
214,041
+76,054
+55% +$229K ﹤0.01% 3113
2020
Q4 		$336K Buy
137,987
+4,373
+3% +$10.5K ﹤0.01% 3161
2020
Q3 		$281K Buy
133,614
+22,782
+21% +$76.8K ﹤0.01% 3163
2020
Q2 		$419K Buy
110,832
+38,447
+53% +$115K ﹤0.01% 3108
2020
Q1 		$137K Buy
+72,385
New +$188K ﹤0.01% 3242

Dimensional Fund Advisors's SBBP Position: Q4 2021 in Review

Dimensional Fund Advisors sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 576,979 shares — an estimated $1.18M sold.

Dimensional Fund Advisors first reported a position in SBBP in Q1 2020 and held it in 7 quarters. The position peaked at $1.64M in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Dimensional Fund Advisors reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 576,979 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $1.18M.
  • Dimensional Fund Advisors first reported a position in Strongbridge Biopharma plc. in Q1 2020 and held it in 7 quarters.
  • Dimensional Fund Advisors's Strongbridge Biopharma plc. position peaked at $1.64M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Dimensional Fund Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.